Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cells
使用 HCI-2509 进行可逆性 LSD1 抑制可诱导高危神经母细胞瘤细胞中的 p53 基因表达特征并破坏 MYCN 特征
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.24035
Sumati Gupta, Kelly Doyle, Timothy L Mosbruger, Andrew Butterfield, Alexis Weston, Allison Ast, Mohan Kaadige, Anupam Verma, Sunil Sharma
